Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-22-014723

VP Finance/Prin Fin&Acct Offic bought 18,800 shares at an average $0.29 ($5,384)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Austin Mark John VP Finance/Prin Fin&Acct Offic 2022-06-08 Purchase +5,000 $0.29 $1,425 40,230 D
Austin Mark John VP Finance/Prin Fin&Acct Offic 2022-06-09 Purchase +13,800 $0.29 $3,959 54,030 D
Open-market purchases · 18,800 sh · avg $0.29 · $5,384
Loading xslF345X03/rdgdoc.xml…